Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

POSITIVE THYROTROPIN RECEPTOR ANTIBODIES IN PATIENTS WITH TRANSIENT THYROTOXICOSIS.

Angell TE, Van Benschoten O, Cohen DA, Haas AV, Alexander EK, Marqusee E.

Endocr Pract. 2018 Jun;24(6):512-516. doi: 10.4158/EP-2018-0059. Epub 2018 Apr 6.

PMID:
29624097
2.

Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients ≥70 Years Old.

Wang Z, Vyas CM, Van Benschoten O, Nehs MA, Moore FD Jr, Marqusee E, Krane JF, Kim MI, Heller HT, Gawande AA, Frates MC, Doubilet PM, Doherty GM, Cho NL, Cibas ES, Benson CB, Barletta JA, Zavacki AM, Larsen PR, Alexander EK, Angell TE.

Thyroid. 2018 Apr;28(4):465-471. doi: 10.1089/thy.2017.0655. Epub 2018 Apr 2.

PMID:
29608439
3.

Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule.

Angell TE, Vyas CM, Barletta JA, Cibas ES, Cho NL, Doherty GM, Gawande AA, Howitt BE, Krane JF, Marqusee E, Strickland KC, Alexander EK, Moore FD Jr, Nehs MA.

Ann Surg Oncol. 2018 May;25(5):1410-1417. doi: 10.1245/s10434-018-6421-x. Epub 2018 Mar 8.

PMID:
29520656
4.

Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP).

Strickland KC, Eszlinger M, Paschke R, Angell TE, Alexander EK, Marqusee E, Nehs MA, Jo VY, Lowe A, Vivero M, Hollowell M, Qian X, Wieczorek T, French CA, Teot LA, Cibas ES, Lindeman NI, Krane JF, Barletta JA.

Endocr Pathol. 2018 Mar;29(1):68-74. doi: 10.1007/s12022-018-9515-x.

PMID:
29396809
5.

Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study.

Hanna GJ, Busaidy NL, Chau NG, Wirth LJ, Barletta JA, Calles A, Haddad RI, Kraft S, Cabanillas ME, Rabinowits G, O'Neill A, Limaye SA, Alexander EK, Moore FD Jr, Misiwkeiwicz K, Thomas T, Nehs M, Marqusee E, Lee SL, Jänne PA, Lorch JH.

Clin Cancer Res. 2018 Apr 1;24(7):1546-1553. doi: 10.1158/1078-0432.CCR-17-2297. Epub 2018 Jan 4.

PMID:
29301825
6.

Differential Growth Rates of Benign vs. Malignant Thyroid Nodules.

Angell TE, Vyas CM, Medici M, Wang Z, Barletta JA, Benson CB, Cibas ES, Cho NL, Doherty GM, Doubilet PM, Frates MC, Gawande AA, Heller HT, Kim MI, Krane JF, Marqusee E, Moore FD Jr, Nehs MA, Zavacki AM, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4642-4647. doi: 10.1210/jc.2017-01832.

PMID:
29040691
7.

A case of primary secretory carcinoma of the thyroid with high-grade features.

Wu EY, Lebastchi J, Marqusee E, Lorch JH, Krane JF, Barletta JA.

Histopathology. 2017 Oct;71(4):665-669. doi: 10.1111/his.13268. Epub 2017 Jul 13. No abstract available.

8.

Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.

Baca SC, Wong KS, Strickland KC, Heller HT, Kim MI, Barletta JA, Cibas ES, Krane JF, Marqusee E, Angell TE.

Cancer Cytopathol. 2017 May;125(5):313-322. doi: 10.1002/cncy.21827. Epub 2017 Feb 2.

9.

HIGH-DOSE BIOTIN TREATMENT FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS MAY INTERFERE WITH THYROID ASSAYS.

Minkovsky A, Lee MN, Dowlatshahi M, Angell TE, Mahrokhian LS, Petrides AK, Melanson SE, Marqusee E, Woodmansee WW.

AACE Clin Case Rep. 2016 Fall;2(4):e370-e373.

10.

Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma.

Kakarmath S, Heller HT, Alexander CA, Cibas ES, Krane JF, Barletta JA, Lindeman NI, Frates MC, Benson CB, Gawande AA, Cho NL, Nehs M, Moore FD, Marqusee E, Kim MI, Larsen PR, Kwong N, Angell TE, Alexander EK.

J Clin Endocrinol Metab. 2016 Dec;101(12):4938-4944. Epub 2016 Sep 30.

11.

Thyroid function and cardiovascular disease risk factors in euthyroid adults: a cross-sectional and longitudinal study.

Lee JJ, Pedley A, Marqusee E, Sutherland P, Hoffmann U, Massaro JM, Fox CS.

Clin Endocrinol (Oxf). 2016 Dec;85(6):932-941. doi: 10.1111/cen.13124. Epub 2016 Jul 14.

12.

Long- versus short-interval follow-up of cytologically benign thyroid nodules: a prospective cohort study.

Medici M, Liu X, Kwong N, Angell TE, Marqusee E, Kim MI, Alexander EK.

BMC Med. 2016 Jan 27;14:11. doi: 10.1186/s12916-016-0554-1.

13.

Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis.

Liu X, Medici M, Kwong N, Angell TE, Marqusee E, Kim MI, Larsen PR, Cho NL, Nehs MA, Ruan DT, Gawande A, Moore F Jr, Barletta J, Krane JF, Cibas ES, Yang T, Alexander EK.

Thyroid. 2016 Feb;26(2):256-61. doi: 10.1089/thy.2015.0376. Epub 2015 Dec 16.

14.

The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk.

Kwong N, Medici M, Angell TE, Liu X, Marqusee E, Cibas ES, Krane JF, Barletta JA, Kim MI, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2015 Dec;100(12):4434-40. doi: 10.1210/jc.2015-3100. Epub 2015 Oct 14.

15.

Afirma Benign Thyroid Nodules Show Similar Growth to Cytologically Benign Nodules During Follow-Up.

Angell TE, Frates MC, Medici M, Liu X, Kwong N, Cibas ES, Kim MI, Marqusee E.

J Clin Endocrinol Metab. 2015 Nov;100(11):E1477-83. doi: 10.1210/jc.2015-2658. Epub 2015 Sep 9.

16.

The variable phenotype and low-risk nature of RAS-positive thyroid nodules.

Medici M, Kwong N, Angell TE, Marqusee E, Kim MI, Frates MC, Benson CB, Cibas ES, Barletta JA, Krane JF, Ruan DT, Cho NL, Gawande AA, Moore FD Jr, Alexander EK.

BMC Med. 2015 Aug 7;13:184. doi: 10.1186/s12916-015-0419-z.

17.

The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.

Strickland KC, Howitt BE, Marqusee E, Alexander EK, Cibas ES, Krane JF, Barletta JA.

Thyroid. 2015 Sep;25(9):987-92. doi: 10.1089/thy.2014.0612. Epub 2015 Jul 29.

PMID:
26114752
18.

Long-term, treatment-free survival in select patients with distant metastatic papillary thyroid cancer.

Kwong N, Marqusee E, Gordon MS, Larsen PR, Garber JR, Kim MI, Alexander EK.

Endocr Connect. 2014 Dec;3(4):207-14. doi: 10.1530/EC-14-0097. Epub 2014 Oct 14.

19.

How are childhood thyroid nodules discovered: opportunities for improving early detection.

Gupta A, Ly S, Castroneves LA, Frates MC, Benson CB, Feldman HA, Wassner AJ, Smith JR, Marqusee E, Alexander EK, Barletta J, Muyide F, Doubilet PM, Peters HE, Webb S, Modi BP, Paltiel HJ, Martins Y, Burmeister K, Kozakewich H, Hollowell M, Cibas ES, Moore FD Jr, Shamberger RC, Larsen PR, Huang SA.

J Pediatr. 2014 Mar;164(3):658-60. doi: 10.1016/j.jpeds.2013.10.090. Epub 2013 Dec 15.

20.

Determination of the optimal time interval for repeat evaluation after a benign thyroid nodule aspiration.

Nou E, Kwong N, Alexander LK, Cibas ES, Marqusee E, Alexander EK.

J Clin Endocrinol Metab. 2014 Feb;99(2):510-6. doi: 10.1210/jc.2013-3160. Epub 2013 Nov 25. Erratum in: J Clin Endocrinol Metab. 2015 Jun;100(6):2502.

21.

A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults.

Gupta A, Ly S, Castroneves LA, Frates MC, Benson CB, Feldman HA, Wassner AJ, Smith JR, Marqusee E, Alexander EK, Barletta J, Doubilet PM, Peters HE, Webb S, Modi BP, Paltiel HJ, Kozakewich H, Cibas ES, Moore FD Jr, Shamberger RC, Larsen PR, Huang SA.

J Clin Endocrinol Metab. 2013 Aug;98(8):3238-45. doi: 10.1210/jc.2013-1796. Epub 2013 Jun 4.

22.

Subacute granulomatous (de Quervain) thyroiditis: grayscale and color Doppler sonographic characteristics.

Frates MC, Marqusee E, Benson CB, Alexander EK.

J Ultrasound Med. 2013 Mar;32(3):505-11.

PMID:
23443191
23.

Thyroid nodule size and prediction of cancer.

Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H, Benson CB, Doubilet PM, Cibas ES, Barletta J, Cho N, Gawande A, Ruan D, Moore FD Jr, Pou K, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2013 Feb;98(2):564-70. doi: 10.1210/jc.2012-2968. Epub 2012 Dec 28.

PMID:
23275525
24.

Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for reporting thyroid cytopathology.

VanderLaan PA, Marqusee E, Krane JF.

Cancer Cytopathol. 2012 Aug 25;120(4):245-53. doi: 10.1002/cncy.21189. Epub 2012 Mar 20.

25.

Repeatedly nondiagnostic thyroid fine-needle aspirations do not modify malignancy risk.

Jo VY, Vanderlaan PA, Marqusee E, Krane JF.

Acta Cytol. 2011;55(6):539-43. doi: 10.1159/000333230. Epub 2011 Dec 9.

PMID:
22156463
26.

Thyroid dysfunction from antineoplastic agents.

Hamnvik OP, Larsen PR, Marqusee E.

J Natl Cancer Inst. 2011 Nov 2;103(21):1572-87. doi: 10.1093/jnci/djr373. Epub 2011 Oct 18. Review.

27.

Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance.

VanderLaan PA, Marqusee E, Krane JF.

Am J Clin Pathol. 2011 Oct;136(4):572-7. doi: 10.1309/AJCPO0BQ2YSKPXXP.

PMID:
21917679
28.

Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?

VanderLaan PA, Marqusee E, Krane JF.

Am J Clin Pathol. 2011 May;135(5):770-5. doi: 10.1309/AJCP4P2GCCDNHFMY.

PMID:
21502433
29.

The predictive value of the fine-needle aspiration diagnosis "suspicious for a follicular neoplasm, hurthle cell type" in patients with hashimoto thyroiditis.

Roh MH, Jo VY, Stelow EB, Faquin WC, Zou KH, Alexander EK, Larsen PR, Marqusee E, Benson CB, Frates MC, Gawande A, Moore FD Jr, Cibas ES.

Am J Clin Pathol. 2011 Jan;135(1):139-45. doi: 10.1309/AJCP0RW2WMDUAKGK.

PMID:
21173136
30.

Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome.

Smith JR, Marqusee E, Webb S, Nose V, Fishman SJ, Shamberger RC, Frates MC, Huang SA.

J Clin Endocrinol Metab. 2011 Jan;96(1):34-7. doi: 10.1210/jc.2010-1315. Epub 2010 Oct 20.

PMID:
20962022
31.

Thyroid hormone early adjustment in pregnancy (the THERAPY) trial.

Yassa L, Marqusee E, Fawcett R, Alexander EK.

J Clin Endocrinol Metab. 2010 Jul;95(7):3234-41. doi: 10.1210/jc.2010-0013. Epub 2010 May 12.

PMID:
20463094
32.

Malignant struma ovarii.

Yassa L, Sadow P, Marqusee E.

Nat Clin Pract Endocrinol Metab. 2008 Aug;4(8):469-72. doi: 10.1038/ncpendmet0887. Epub 2008 Jun 17.

PMID:
18560398
33.

Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation.

Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore FD Jr, Kim BW, Nosé V, Marqusee E, Larsen PR, Alexander EK.

Cancer. 2007 Dec 25;111(6):508-16.

34.

Serum calcitonin measurements in the preoperative diagnosis of medullary thyroid carcinoma.

Marqusee E.

Nat Clin Pract Endocrinol Metab. 2007 May;3(5):392-3. Epub 2007 Mar 20. No abstract available.

PMID:
17375054
35.

Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.

Desai J, Yassa L, Marqusee E, George S, Frates MC, Chen MH, Morgan JA, Dychter SS, Larsen PR, Demetri GD, Alexander EK.

Ann Intern Med. 2006 Nov 7;145(9):660-4.

PMID:
17088579
36.

Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography.

Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen PR, Marqusee E, Alexander EK.

J Clin Endocrinol Metab. 2006 Sep;91(9):3411-7. Epub 2006 Jul 11.

PMID:
16835280
37.

CD1a and CD1c activate intrathyroidal T cells during Graves' disease and Hashimoto's thyroiditis.

Roura-Mir C, Catálfamo M, Cheng TY, Marqusee E, Besra GS, Jaraquemada D, Moody DB.

J Immunol. 2005 Mar 15;174(6):3773-80.

38.

Thyroid nodule shape and prediction of malignancy.

Alexander EK, Marqusee E, Orcutt J, Benson CB, Frates MC, Doubilet PM, Cibas ES, Atri A.

Thyroid. 2004 Nov;14(11):953-8.

PMID:
15671774
39.

Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism.

Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR.

N Engl J Med. 2004 Jul 15;351(3):241-9.

40.

Natural history of benign solid and cystic thyroid nodules.

Alexander EK, Hurwitz S, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, Larsen PR, Marqusee E.

Ann Intern Med. 2003 Feb 18;138(4):315-8.

PMID:
12585829
41.

Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules?

Frates MC, Benson CB, Doubilet PM, Cibas ES, Marqusee E.

J Ultrasound Med. 2003 Feb;22(2):127-31; quiz 132-4.

PMID:
12562117
42.

Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules.

Alexander EK, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, Marqusee E.

J Clin Endocrinol Metab. 2002 Nov;87(11):4924-7.

PMID:
12414851
43.

The effect of droloxifene and estrogen on thyroid function in postmenopausal women.

Marqusee E, Braverman LE, Lawrence JE, Carroll JS, Seely EW.

J Clin Endocrinol Metab. 2000 Nov;85(11):4407-10.

PMID:
11095487
44.

Usefulness of ultrasonography in the management of nodular thyroid disease.

Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES, Mandel SJ.

Ann Intern Med. 2000 Nov 7;133(9):696-700.

PMID:
11074902
45.

Subclinical thyrotoxicosis.

Marqusee E, Haden ST, Utiger RD.

Endocrinol Metab Clin North Am. 1998 Mar;27(1):37-49. Review.

PMID:
9534026
46.

Thyroiditis after pregnancy loss.

Marqusee E, Hill JA, Mandel SJ.

J Clin Endocrinol Metab. 1997 Aug;82(8):2455-7.

PMID:
9253317

Supplemental Content

Loading ...
Support Center